Oxadiazole derivatives with antiinflammatory and immunosuppressive properties

Details for Australian Patent Application No. 2007302262 (hide)

Owner Novartis AG

Inventors Lewis, Ian; Weiler, Sven; Zecri, Frederic; Cooke, Nigel Graham; Albert, Rainer

Agent Davies Collison Cave

Pub. Number AU-A-2007302262

PCT Pub. Number WO2008/037476

Priority 06121495.3 29.09.06 EP

Filing date 27 September 2007

Wipo publication date 3 April 2008

International Classifications

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

Event Publications

12 March 2009 PCT application entered the National Phase

  PCT publication WO2008/037476 Priority application(s): WO2008/037476

10 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007302263-Pyrazolopyrimidines as P13K lipid kinase inhibitors

2007302256-Directional use